ERAS
Price
$1.57
Change
-$0.01 (-0.63%)
Updated
Aug 28 closing price
Capitalization
445.36M
68 days until earnings call
IMUX
Price
$0.87
Change
+$0.02 (+2.35%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
85.83M
70 days until earnings call
Interact to see
Advertisement

ERAS vs IMUX

Header iconERAS vs IMUX Comparison
Open Charts ERAS vs IMUXBanner chart's image
Erasca
Price$1.57
Change-$0.01 (-0.63%)
Volume$338.84K
Capitalization445.36M
Immunic
Price$0.87
Change+$0.02 (+2.35%)
Volume$11.54K
Capitalization85.83M
ERAS vs IMUX Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. IMUX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a Buy and IMUX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ERAS: $1.57 vs. IMUX: $0.87)
Brand notoriety: ERAS and IMUX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 44% vs. IMUX: 50%
Market capitalization -- ERAS: $445.36M vs. IMUX: $85.83M
ERAS [@Biotechnology] is valued at $445.36M. IMUX’s [@Biotechnology] market capitalization is $85.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileIMUX’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • IMUX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ERAS and IMUX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 6 TA indicator(s) are bullish while IMUX’s TA Score has 4 bullish TA indicator(s).

  • ERAS’s TA Score: 6 bullish, 3 bearish.
  • IMUX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than IMUX.

Price Growth

ERAS (@Biotechnology) experienced а +4.67% price change this week, while IMUX (@Biotechnology) price change was -7.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 05, 2025.

IMUX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERAS($445M) has a higher market cap than IMUX($85.8M). IMUX YTD gains are higher at: -14.510 vs. ERAS (-37.450). IMUX has higher annual earnings (EBITDA): -105.1M vs. ERAS (-135.93M). ERAS has more cash in the bank: 301M vs. IMUX (55.3M). IMUX has less debt than ERAS: IMUX (979K) vs ERAS (49.4M). ERAS (0) and IMUX (0) have equivalent revenues.
ERASIMUXERAS / IMUX
Capitalization445M85.8M519%
EBITDA-135.93M-105.1M129%
Gain YTD-37.450-14.510258%
P/E RatioN/AN/A-
Revenue00-
Total Cash301M55.3M544%
Total Debt49.4M979K5,046%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASIMUX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVAHF0.06N/A
+1.49%
EGF THERAMED HEALTH CORP.
GBBYF0.17N/A
N/A
Goodbaby International Holdings Ltd
HSTI1.40N/A
N/A
High Sierra Technologies Inc.
BVVBY60.50-0.43
-0.71%
Bureau Veritas SA
BVNRY12.16-0.20
-1.66%
Bavarian Nordic A/S

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
-0.63%
XNCR - ERAS
53%
Loosely correlated
+0.37%
RVMD - ERAS
53%
Loosely correlated
+0.75%
OCUL - ERAS
53%
Loosely correlated
+1.62%
BEAM - ERAS
51%
Loosely correlated
-0.06%
IRON - ERAS
50%
Loosely correlated
-0.48%
More

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with PLRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-2.85%
PLRX - IMUX
36%
Loosely correlated
+4.32%
ERAS - IMUX
35%
Loosely correlated
-1.25%
NTLA - IMUX
35%
Loosely correlated
+0.53%
ORIC - IMUX
34%
Loosely correlated
+4.16%
IPSC - IMUX
33%
Loosely correlated
+1.26%
More